Authors:
TESSON F
DUFOUR C
MOOLMAN JC
CARRIER L
ALMAHDAWI S
CHOJNOWSKA L
DUBOURG O
SOUBRIER F
BRINK P
KOMAJDA M
GUICHENEY P
SCHWARTZ K
FEINGOLD J
Citation: F. Tesson et al., THE INFLUENCE OF THE ANGIOTENSIN-I CONVERTING-ENZYME GENOTYPE IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY VARIES WITH THE DISEASE GENE MUTATION, Journal of Molecular and Cellular Cardiology, 29(2), 1997, pp. 831-838
Citation: Jc. Moolman et al., IDENTIFICATION OF A NOVEL ALAL97THR MUTATION IN EXON-21 OF THE BETA-MYOSIN HEAVY-CHAIN GENE IN HYPERTROPHIC CARDIOMYOPATHY, Human mutation, 6(2), 1995, pp. 197-198
Citation: Bm. Posen et al., CLINICAL AND PROGNOSTIC EVALUATION OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY IN 2 SOUTH-AFRICAN FAMILIES WITH DIFFERENT CARDIAC BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS, British Heart Journal, 74(1), 1995, pp. 40-46
Authors:
BRINK PA
MOOLMAN JC
FERREIRA A
DEJAGER T
WEYMAR HW
MARTELL RW
TORRINGTON M
VANDERMERWE PL
CORFIELD VA
Citation: Pa. Brink et al., GENETIC-LINKAGE STUDIES OF PROGRESSIVE FAMILIAL HEART-BLOCK, A CARDIAC CONDUCTION DISORDER, South African journal of science, 90(4), 1994, pp. 236-240
Citation: Jc. Moolman et al., IDENTIFICATION OF A NEW MISSENSE MUTATION AT ARG403, A CPG MUTATION HOTSPOT, IN EXON-13 OF THE BETA-MYOSIN HEAVY-CHAIN GENE IN HYPERTROPHICCARDIOMYOPATHY, Human molecular genetics, 2(10), 1993, pp. 1731-1732